RA PHARMA Trademark

Trademark Overview

On Wednesday, January 6, 2016, a trademark application was filed for RA PHARMA with the United States Patent and Trademark Office. The USPTO has given the RA PHARMA trademark a serial number of 86867358. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 3, 2023. This trademark is owned by Ra Pharmaceuticals, Inc.. The RA PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development in the field of peptides and/or peptidomimetics; the foregoing services not related to rheumatoid arthritis
ra pharma

General Information

Serial Number86867358
Word MarkRA PHARMA
Filing DateWednesday, January 6, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 3, 2023
Registration Number5022228
Registration DateTuesday, August 16, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2016

Trademark Statements

Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesPharmaceutical research and development in the field of peptides and/or peptidomimetics; the foregoing services not related to rheumatoid arthritis

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 3, 2023
Primary Code042
First Use Anywhere DateThursday, December 8, 2011
First Use In Commerce DateThursday, December 8, 2011

Trademark Owner History

Party NameRa Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameRa Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRa Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, March 3, 2023CANCELLED SEC. 8 (6-YR)
Thursday, July 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 7, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, July 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 25, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 25, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 25, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 16, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 24, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 24, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 16, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, July 27, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 31, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 27, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 27, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, April 27, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, April 27, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, April 21, 2016ASSIGNED TO EXAMINER
Thursday, January 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 9, 2016NEW APPLICATION ENTERED

Related Keywords

pharma services related rheumatoid arthritis foregoing peptidomimetics research development field peptides